Show simple item record

dc.contributor.authorLee, Andy
dc.contributor.authorFraser, Michelle
dc.contributor.authorBinns, Colin
dc.date.accessioned2017-01-30T11:37:18Z
dc.date.available2017-01-30T11:37:18Z
dc.date.created2008-11-12T23:24:56Z
dc.date.issued2005
dc.identifier.citationLee, Andy and Fraser, Michelle and Binns, Colin. 2005. Possible role for green tea in ovarian cancer prevention. Future Oncology 1 (6): 771-777.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/13474
dc.identifier.doi10.2217/14796694.1.6.771
dc.description.abstract

Ovarian cancer is the leading cause of death from gynecologic cancer. Tea, especially green tea, has shown promise in the prevention of several cancers. Green tea contains a number of compounds, including polyphenols, that have chemopreventive properties. There is much evidence from in vitro and animal studies suggesting that components of tea are associated with decreased risk or progression of ovarian cancer. However, epidemiologic studies have generated inconsistent results. Recent research conducted in China reported reduced risk of ovarian cancer and increased survival post diagnosis with green tea consumption. This review presents emerging evidence and the authors' perspectives on the role of green tea in ovarian cancer prevention.

dc.publisherFuture Medicine
dc.relation.urihttp://www.futuremedicine.com/loi/fon
dc.subjectovarian cancer
dc.subjectgreen tea
dc.subjectcatechins
dc.subjectpolyphenols
dc.subjectepidemiologic studies
dc.subjectbiologic mechanisms
dc.titlePossible role for green tea in ovarian cancer prevention
dc.typeJournal Article
dcterms.source.volume1
dcterms.source.number6
dcterms.source.startPage771
dcterms.source.endPage777
dcterms.source.titleFuture Oncology
curtin.identifierEPR-712
curtin.accessStatusOpen access
curtin.facultySchool of Public Health
curtin.facultyDivision of Health Sciences


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record